Search

Search Constraints

You searched for: Author/Creator Minami, Hironobu

Search Results

11. Cryptic insertion of CBFB into MYH11 leading to a type D fusion in acute myeloid leukemia with normal karyotype. (6th September 2021)

12. Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma. Issue 5 (11th May 2017)

14. Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia. (December 2019)

15. Disseminated cryptococcosis resembling miliary tuberculosis in a patient with acute myeloid leukemia. Issue 11 (November 2020)

16. Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia. Issue 3 (29th June 2021)

17. Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study. (December 2018)

18. Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study. Issue 6 (15th June 2017)

19. Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open‐label phase 2 trial. Issue 9 (3rd September 2019)

20. Exploratory analysis of prognostic factors for lenvatinib in radioiodine‐refractory differentiated thyroid cancer. Issue 9 (23rd April 2019)